Embla Medical – Recording of Q2 2024 presentation
![](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90,fit=cover/https://content.inderes.se/assets/c5819ee6-fd44-433c-8a4f-224f6eca9445.png)
Today, Embla Medical's CEO Sveinn Solvason presented the Q2 2024 results, the expectations for the rest of the year, and details about Medicare's finalized proposal that grants access to more advanced solutions for more patients in the US.
Watch the recording here: https://www.inderes.dk/videos/embla-medical-presentation-of-interim-report-q2-2024
Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying Patient Care. Headquartered in Iceland, the company employs over 4,000. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.
Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis, 17:22, 23 July 2024.
Login required
This content is only available for logged in users
Embla Medical
Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying patient care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.
Read more on company page